Clinical trial design for new cancer therapies has historically been focused on the tissue of origin of a tumor, but a paper from researchers at Memorial Sloan-Kettering Cancer Center published on September 26 in Nature Genetics ...
Sep 27, 2013
0
0
In an impressive showing of alliteration, Sen. Chuck Schumer recently described the trending nicotine product Zyn as a "pouch packed with problems" while delivering a warning to parents and calling for a federal investigation ...
Mar 8, 2024
1
2
Physical activity may be what the doctor orders to help patients reduce their risk of developing glaucoma. According to a recently published scientific paper, higher levels of physical exercise appear to have a long-term ...
Oct 24, 2011
0
0
Cigarette smoking is a well-known risk factor for a wide-range of diseases. Now, scientists have evidence that smoking may also increase the risk of age-related cataract, the leading cause of blindness and vision loss in ...
Oct 12, 2012
1
0
A woman said to have been in a vegetative state for at least a decade at a private health care facility in Phoenix reportedly gave birth recently, triggering a police investigation and reviews by state agencies in a situation ...
Jan 5, 2019
1
6
Cologne University Hospital (UKK), University of Marburg (UMR), the German Center for Infection Research (DZIF) and Boehringer Ingelheim today announced the initiation of Phase 1/2a clinical investigation of BI 767551, a ...
Dec 18, 2020
0
3
Approximately 1 billion people worldwide have non-alcoholic fatty liver disease (NAFLD). Individuals with this disease have an increased risk of type 2 diabetes, obesity, and kidney disease. It is not clear how this disease ...
Oct 27, 2014
0
0
The World Health Organization decided Wednesday to halt trials of hydroxychloroquine as a potential treatment for hospitalised COVID-19 patients, finding it did not reduce the mortality rate.
Jun 17, 2020
0
6
For the first time, prostate cancer has been treated based on the genetic makeup of the cancer, resulting in delayed disease progression, delayed time to pain progression, and potentially extending lives in patients with ...
Sep 30, 2019
0
15
A novel therapy in the early stages of development at Virginia Commonwealth University Massey Cancer Center shows promise in providing lasting protection against the progression of multiple myeloma following a stem cell transplant ...
Oct 1, 2012
0
0
